Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2009-012088-32Phase 3Completed
Phase 3, randomised trial of nimodipine in acoustic neuroma (2 arms), sponsored by Martin Luther University Halle-Wittenberg. Primary endpoint: Facial nerve function at 12 months. Started Oct 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2009-012088-32.